Paid Clinical Trials Chico
Discover 20 paid clinical trials in Chico, California. Search by condition or phase to find a research study near you that matches your needs across various therapeutic areas.
MINIject™ ImplantEvaluate the Safety and Effectiveness of iSTAR Medical's MINIject™ Implant for Lowering Intraocular Pressure (IOP) in Subjects With Primary Open-angle Glaucoma.
Sponsor:
iSTAR Medical
Location:
Code:
NCT05024695
Conditions
Glaucoma
Eligibility Criteria
Sex: All
Age: 46+
Healthy Volunteers: Not accepted
Interventions
MINIject™ Implant
Genetic TestingA Pilot Study of Genetic Testing Uptake Through Enhanced Oncology Nurse-Led Intervention
Sponsor:
UCLA
Location:
Code:
NCT06436157
Conditions
Solid Tumor, Adult
Eligibility Criteria
Sex: All
Age: 18+
Healthy Volunteers: Not accepted
Interventions
Enhanced education
Usual care education
MELT-300A Study to Evaluate Efficacy and Safety of MELT-300 for Procedural Sedation in Subjects Undergoing Cataract Extraction With Lens Replacement (CELR)
Sponsor:
Melt Pharmaceuticals
Location:
Code:
NCT06383273
Conditions
Cataract
Eligibility Criteria
Sex: All
Age: 18 - 65
Healthy Volunteers: Not accepted
Interventions
MELT-300 sublingual tablet
Midalozam sublingual tablet
Placebo sublingual tablet
Support ProgramAdditional Support Program Via Text Messaging and Telephone-Based Counseling for Breast Cancer Patients Receiving Hormonal Therapy
Sponsor:
Alliance for Clinical Trials in Oncology
Location:
Code:
NCT04379570
Conditions
Anatomic Stage I Breast Cancer AJCC v8
Anatomic Stage II Breast Cancer AJCC v8
Anatomic Stage III Breast Cancer AJCC v8
HER2 Negative Breast Carcinoma
Hormone Receptor Positive Breast Carcinoma
Eligibility Criteria
Sex: Female
Age: 18+
Healthy Volunteers: Not accepted
Interventions
Educational Intervention
Text Message-based Navigation Intervention
Motivational Interviewing
Best Practice
Questionnaire Administration
Low Dose TamoxifenTesting Low Dose Tamoxifen for Invasive Breast Cancer, the (LoTam) Trial
Sponsor:
Alliance for Clinical Trials in Oncology
Location:
Code:
NCT06671912
Conditions
Anatomic Stage 0 Breast Cancer AJCC v8
Anatomic Stage 1 Breast Cancer AJCC v8
Anatomic Stage IIA Breast Cancer AJCC v8
Estrogen Receptor-Positive Breast Carcinoma
HER2-Negative Breast Carcinoma
Eligibility Criteria
Sex: All
Age: 18+
Healthy Volunteers: Not accepted
Interventions
Anastrozole
Letrozole
Exemestane
Tamoxifen
Mammogram
Interested in new trials?
Get alerts for new trials in your area by subscribing now
Drug CombinationsComparing Combinations of Drugs to Treat Newly Diagnosed Multiple Myeloma (NDMM) When a Stem Cell Transplant is Not a Medically Suitable Treatment
Sponsor:
SWOG Cancer Research Network
Location:
Code:
NCT05561387
Conditions
Plasma Cell Myeloma
Eligibility Criteria
Sex: All
Age: 0 - 70+
Healthy Volunteers: Not accepted
Interventions
Bortezomib
Daratumumab and Hyaluronidase-fihj
Dexamethasone
Lenalidomide
Quality-of-Life Assessment
Darolutamide & Hormone TherapyTwo Studies for Patients With Unfavorable Intermediate Risk Prostate Cancer Testing Less Intense Treatment for Patients With a Low Gene Risk Score and Testing a More Intense Treatment for Patients With a Higher Gene Risk Score, The Guidance Trial
Sponsor:
NRG Oncology
Location:
Code:
NCT05050084
Conditions
Prostate Adenocarcinoma
Eligibility Criteria
Sex: Male
Age: 18+
Healthy Volunteers: Not accepted
Interventions
Bicalutamide
Buserelin
Darolutamide
Degarelix
Flutamide
Venetoclax & ObinutuzumabTesting Early Treatment for Patients With High-Risk Chronic Lymphocytic Leukemia (CLL) or Small Lymphocytic Leukemia (SLL), EVOLVE CLL/SLL Study
Sponsor:
National Cancer Institute (NCI)
Location:
Code:
NCT04269902
Conditions
Chronic Lymphocytic Leukemia
Small Lymphocytic Lymphoma
Eligibility Criteria
Sex: All
Age: 18+
Healthy Volunteers: Not accepted
Interventions
Biospecimen Collection
Bone Marrow Aspiration
Bone Marrow Biopsy
Computed Tomography
Obinutuzumab
Gemcitabine & CisplatinGemcitabine and Cisplatin Without Cystectomy for Patients With Muscle Invasive Bladder Urothelial Cancer and Select Genetic Alterations
Sponsor:
Alliance for Clinical Trials in Oncology
Location:
Code:
NCT03609216
Conditions
Infiltrating Bladder Urothelial Carcinoma
Stage II Bladder Urothelial Carcinoma
Stage III Bladder Urothelial Carcinoma
Eligibility Criteria
Sex: All
Age: 18+
Healthy Volunteers: Not accepted
Interventions
Gemcitabine Hydrochloride
Cisplatin
Pegfilgrastim
Conventional Surgery
Radical Cystectomy
Eribulin vs. ChemotherapyComparing the New Anti-cancer Drug Eribulin With Chemotherapy Against the Usual Chemotherapy Alone in Metastatic Urothelial Cancer
Sponsor:
National Cancer Institute (NCI)
Location:
Code:
NCT04579224
Conditions
Metastatic Bladder Urothelial Carcinoma
Metastatic Urothelial Carcinoma
Refractory Bladder Urothelial Carcinoma
Refractory Urothelial Carcinoma
Stage IV Bladder Cancer AJCC v8
Eligibility Criteria
Sex: All
Age: 18+
Healthy Volunteers: Not accepted
Interventions
Biospecimen Collection
Bone Scan
Computed Tomography
Docetaxel
Eribulin Mesylate